Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Diasorin

Request full access

Multinational biotech company

Saluggia, ItalyFounded 1968Biotech & Life Sciences

About Diasorin

DiaSorin—publicly listed on the FTSE MIB Index since 2007— is an Italy-based company globally operating in laboratory diagnostics. It develops, produces and markets testing devices and equipment that enable doctors worldwide to make accurate diagnosis. Every second, 10 people in the world encounter DiaSorin. DiaSorin’s success lies in its ongoing biotechnological innovation driven by large-scale investments in research and development. Every year, the Company launches about 10 new diagnostic tests. Research is at the core of the Group’s achievements in the world of laboratory diagnostics. More than 200 employees are committed to developing state-of-the-art specialized testing solutions that assist doctors and laboratory teams in the difficult task of providing effective and efficient results, specifically meeting with their niche testing needs. The choice to develop niche test services alongside more common diagnostic tests has allowed the Group to become a leading player in a very innovative and competitive market and to be internationally recognized as the “Specialist” in the diagnostic field. DiaSorin is present worldwide with 26 companies, 4 branches, 5 production sites and 5 research and development centers. The company operates directly in Europe, Israel, the United States, Canada, Mexico, Brazil, China, India and Australia. The rest of the world is served by more than 200 independent distributors with whom the Group maintains strong relationships in order to offer the best possible service to all its customers.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2007
Employees
2,877
Open positions
78
Dealroom signal
51.9/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Infections and Infectious Diseases, Research and Development, Screening, observatoire healthtech
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company, latest Apr 2021
Capital deployed
—
Preferred round
ACQUISITION

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANT✓Other financing Nov 2020 $820K — Undisclosed —
GRANT✓Other financing Jul 2020 $111K — HHS Administration for Strategic Preparedness and Response —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Diasorin website traffic

Latest recorded traffic for Diasorin is 27K monthly website visits, up 35% over the last three months. Diasorin's team grew 86.8% over the past year.

Latest monthly visits27K 3-month web change+35% 1-year team growth+86.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Diasorin in the Saluggia ecosystem

Live from Dealroom

The Diasorin office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • HHS Administration for Strategic Preparedness and Response

Other known investors1 additional known investor

  • US Biomedical Advanced Research and Development Authority
Team profiled 20 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇮🇹 Italy · Saluggia HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Diasorin on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Diasorin’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.